Clinicopath Conf
Metastatic Malignant Melanoma, "Encephalitic"Form, in Leptomeninges and Cerebral Cortex, Case 28-199, , NE27:107-116,1992., 1992
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
Dural Melanocytoma with Leptomeningeal Melanocytosis
Neurol 88:e70-e71, Schembri, M.,et al, 2017
Neurological, Respiratory, Musculoskeletal, Cardiac and Ocular Side-Effects of Anti-PD-1 Therapy
Eur J Cancer 60:210-225, Zimmer, L.,et al, 2016
Leptomeningeal Metastases in the MRI Era
Neurol 74:1449-1454, Clarke,J.L., et al, 2010
Ventriculoperitoneal Shunt in Patients with Leptomeningeal Metastasis
Neurol 64:1625-1627, Omuro,A.M.P.,et al, 2005
Primary Diffuse Meningeal Melanomatosis: Radiologic-Pathologic Correlation
AJNR 24:115-118, Pirini,M.,et al, 2003
Neoplastic Meningitis in Malignant Melanoma:Diagnosis with Monoclonal Antibodies
JNNP 52:881-886, Moseley,R.P.,et al, 1989
Meningeal Carcinomatosis
Arch Neurol 38:696-699, Theodore,W.H.,et al, 1981
Primary Malignant Melanomatosis of the Meninges
Arch Neurol 38:528-529, Crisp,D.E.,et al, 1981
Malignant Melanoma and Central Nervous System Metastases, Incidence, Diagnosis, Treatment and Survival
Cancer 42:660-668, Amer,M.H.,et al, 1978
Infiltration of the Leptomeninges by Systemic Cancer:a Clinical & Pathologic Study
Arch Neurol 30:122, Olson,M.E.,et al, 1974
Hypoglycorrhachia in Meningeal Carcinomatosis
Cancer 19:691-694, DeVita,V.T.&Canellos,G.P., 1966